Neuraxis declares Q3 2026 Series B stock dividend

Series B holders of record on October 26 are scheduled to receive the common-stock dividend on October 30, with cash replacing fractional shares.

Rhea-AI Filing Summary

Neuraxis, Inc. authorized and declared a third-quarter 2026 stock dividend on its Series B Preferred Stock, payable in shares of Common Stock. Approximately 81,339 Common Stock shares are expected to be issued. Each holder’s share amount will be based on accrued and unpaid Series B dividends from July 1, 2026 through the record date, divided by $2.38.

The dividend is payable on October 30, 2026 to Series B holders of record at the close of business on October 26, 2026. No fractional Common Stock shares will be issued; holders otherwise entitled to a fraction will receive cash, without interest or deduction, equal to $2.38 multiplied by the fraction of one Series B Preferred Stock share they own.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Expected Common Stock shares: Approximately 81,339 shares Calculation divisor: $2.38 Record date: October 26, 2026 +1 more

4 metrics

Expected Common Stock shares Approximately 81,339 shares Expected issuance for the third-quarter 2026 stock dividend

Calculation divisor $2.38 Used to determine each holder’s Common Stock share amount

Record date October 26, 2026 Series B Preferred Stock holders of record at close of business

Payment date October 30, 2026 Third-quarter 2026 stock dividend

Key Terms

stock dividend, accrued and unpaid dividends, holders of record, fractional shares

4 terms

stock dividend financial

"declared a stock dividend on the Company’s Series B Preferred Stock"

A stock dividend is when a company gives its existing shareholders extra shares instead of cash. It’s like receiving more pieces of the same pie rather than a bigger piece of money, which can increase the number of shares you own but usually doesn’t change the total value of your investment right away. Investors care about it because it can signal the company's growth and affect the stock’s price.

accrued and unpaid dividends financial

"based on the accrued and unpaid dividends on such holder’s Series B Preferred Stock"

Accrued and unpaid dividends are dividend payments that a company has declared or owes to shareholders but has not yet actually paid out. For investors this matters because it represents cash they expect to receive—like a paycheck that’s been earned but not yet issued—and signals the company’s payment priorities and short-term cash health, which can affect shareholder returns and claims in cases like restructuring.

holders of record financial

"to holders of record of the Company’s Series B Preferred Stock"

Names listed on a company’s official register at a specific cut-off date who are legally entitled to receive dividends, vote on corporate matters, or participate in other shareholder actions. Think of it like a guest list for an event: only those on the list at the snapshot time get the invitation or benefits, so investors watch the record date to know whether they will receive payouts or voting rights for a given corporate action.

fractional shares financial

"No fractional shares will be issued in connection with the Third Quarter Dividend"

Fractional shares are portions of a whole share of a stock or fund, allowing investors to own less than one full unit. They make it possible to invest a specific dollar amount rather than buy whole shares, like buying a slice of a pizza instead of the entire pie. For investors this lowers the cost barrier, helps with diversification, and lets you reinvest dividends or purchase expensive stocks in small, precise amounts.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRXS shares are expected for the third-quarter 2026 Series B dividend?

Approximately 81,339 shares of Common Stock are expected to be issued. Each holder’s amount is based on accrued and unpaid dividends on their Series B Preferred Stock from July 1, 2026 through the record date, divided by $2.38.

When will NRXS pay the Series B stock dividend, and how are fractional shares handled?

The dividend is payable on October 30, 2026 to holders of record at the close of business on October 26, 2026. No fractional Common Stock shares will be issued; holders entitled to a fraction will receive cash, without interest or deduction, equal to $2.38 multiplied by the fraction of one Series B Preferred Stock share they own.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/14/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/14/2026 - 05:00 PM EDT Learn about SEC filing dates

false 0001933567 0001933567 2026-10-14 2026-10-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 14, 2026

Neuraxis, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-41775		45-5079684
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

11611 N. Meridian St, Suite 330

Carmel, IN 46032

(Address of principal executive offices)

Registrant’s telephone number, including area code: (812) 689-0791

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value		NRXS		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events

On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “Company”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) for the third quarter of 2026 (the “Third Quarter Dividend”). The Third Quarter Dividend will be paid in the form of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The number of shares of Common Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series B Preferred Stock from July 1, 2026 through the record date, divided by $2.38. A total of approximately 81,339 shares of Common Stock are expected to be issued in connection with the Third Quarter Dividend. No fractional shares will be issued in connection with the Third Quarter Dividend. In lieu of any fractional shares, holders of Series B Preferred Stock who would otherwise be entitled to receive a fractional share of Common Stock will receive cash (without interest or deduction) in an amount equal to the product obtained by multiplying (a) $2.38 by (b) the fraction of one share of Series B Preferred Stock owned by such holder. The Third Quarter Dividend will be payable on October 30, 2026, to holders of record of the Company’s Series B Preferred Stock as of the close of business on October 26, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 14, 2026	NEURAXIS, INC.
	By:	/s/ Brian Carrico
	Name:	Brian Carrico
	Title:	President and Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB